Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ARCA Biopharma Gross Profit 2010-2023 | ABIO

ARCA Biopharma gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
ARCA Biopharma Annual Gross Profit
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
ARCA Biopharma Quarterly Gross Profit
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.046B $0.000B
ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular science, ARCA's management team has significant experience in developing and commercializing cardiovascular products. The Company's business focus combines expertise in cardiovascular pathophysiology, molecular genetics, clinical development and product commercialization. It is currently developing Gencaro (bucindolol hydrochloride), a cardiovascular drug for the treatment of chronic heart failure. The company is based in Broomfield, Colorado.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.292B 14.24
Vertex Pharmaceuticals (VRTX) United States $102.701B 29.57
Regeneron Pharmaceuticals (REGN) United States $98.628B 23.91
Bristol Myers Squibb (BMY) United States $98.318B 6.47
CSL (CSLLY) Australia $86.502B 0.00
Gilead Sciences (GILD) United States $84.354B 10.08
GSK (GSK) United Kingdom $83.934B 10.52
Moderna (MRNA) United States $39.766B 0.00
Biogen (BIIB) United States $28.607B 13.36
Argenex SE (ARGX) Netherlands $22.313B 0.00
BioNTech SE (BNTX) Germany $20.894B 21.33
Genmab (GMAB) Denmark $19.513B 25.01
Illumina (ILMN) United States $19.295B 139.26
Alnylam Pharmaceuticals (ALNY) United States $18.602B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.271B 73.21
BeiGene (BGNE) Cayman Islands $13.237B 0.00
Incyte (INCY) United States $11.996B 19.94
Exact Sciences (EXAS) United States $11.863B 0.00
Sarepta Therapeutics (SRPT) United States $11.109B 0.00
Bio-Techne Corp (TECH) United States $10.299B 38.32
Bio-Rad Laboratories (BIO.B) United States $9.655B 28.76
Legend Biotech (LEGN) United States $9.407B 0.00
Repligen (RGEN) United States $9.291B 96.18
QIAGEN (QGEN) Netherlands $9.053B 18.74
Roivant Sciences (ROIV) United Kingdom $8.735B 0.00
Ascendis Pharma (ASND) Denmark $8.456B 0.00
Viking Therapeutics (VKTX) United States $7.379B 0.00
Cytokinetics (CYTK) United States $7.111B 0.00
Exelixis (EXEL) United States $6.883B 35.47
Vaxcyte (PCVX) United States $6.764B 0.00
Intra-Cellular Therapies (ITCI) United States $6.269B 0.00
Apellis Pharmaceuticals (APLS) United States $6.210B 0.00
Blueprint Medicines (BPMC) United States $5.213B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.984B 0.00
Halozyme Therapeutics (HALO) United States $4.920B 15.18
Krystal Biotech (KRYS) United States $4.840B 0.00
Immunovant (IMVT) United States $4.427B 0.00
Zealand Pharma (ZLDPF) Denmark $4.337B 0.00
Nuvalent (NUVL) United States $4.182B 0.00
Alkermes (ALKS) Ireland $4.064B 21.45
Insmed (INSM) United States $3.984B 0.00
Biohaven (BHVN) United States $3.653B 0.00
ImmunityBio (IBRX) United States $3.548B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.528B 0.00
Fortrea Holdings (FTRE) United States $3.400B 0.00
Iovance Biotherapeutics (IOVA) United States $3.321B 0.00
Axsome Therapeutics (AXSM) United States $3.231B 0.00
Amicus Therapeutics (FOLD) United States $3.149B 0.00
SpringWorks Therapeutics (SWTX) United States $3.137B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.116B 0.00
Apogee Therapeutics (APGE) United States $3.102B 0.00
IDEAYA Biosciences (IDYA) United States $3.095B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.077B 0.00
Arcellx (ACLX) United States $3.035B 0.00
Certara (CERT) United States $2.794B 60.14
MoonLake Immunotherapeutics (MLTX) Switzerland $2.788B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.783B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.767B 0.00
MorphoSys AG (MOR) Germany $2.714B 0.00
Janux Therapeutics (JANX) United States $2.679B 0.00
Vera Therapeutics (VERA) United States $2.534B 0.00
CG Oncology (CGON) United States $2.508B 0.00
Denali Therapeutics (DNLI) United States $2.483B 0.00
Merus (MRUS) Netherlands $2.422B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.411B 0.00
Arvinas (ARVN) United States $2.364B 0.00
Vericel (VCEL) United States $2.356B 0.00
Intellia Therapeutics (NTLA) United States $2.203B 0.00
Celldex Therapeutics (CLDX) United States $2.184B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.173B 0.00
Kymera Therapeutics (KYMR) United States $2.102B 0.00
Beam Therapeutics (BEAM) United States $2.099B 0.00
Guardant Health (GH) United States $2.076B 0.00
Keros Therapeutics (KROS) United States $2.075B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.045B 0.00
Galapagos (GLPG) Belgium $1.964B 0.00
Avidity Biosciences (RNA) United States $1.906B 0.00
Geron (GERN) United States $1.887B 0.00
Sana Biotechnology (SANA) United States $1.885B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.837B 0.00
Neumora Therapeutics (NMRA) United States $1.778B 0.00
NeoGenomics (NEO) United States $1.755B 0.00
Structure Therapeutics (GPCR) United States $1.754B 0.00
Myriad Genetics (MYGN) United States $1.723B 0.00
Bavarian Nordic (BVNRY) Denmark $1.697B 5.57
Twist Bioscience (TWST) United States $1.691B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.676B 13.93
Inhibrx (INBX) United States $1.646B 0.00
Protagonist Therapeutics (PTGX) United States $1.549B 0.00
Edgewise Therapeutics (EWTX) United States $1.534B 0.00
Dynavax Technologies (DVAX) United States $1.530B 0.00
Arcus Biosciences (RCUS) United States $1.480B 0.00
Morphic Holding (MORF) United States $1.477B 0.00
Kura Oncology (KURA) United States $1.448B 0.00
Ligand Pharmaceuticals (LGND) United States $1.412B 17.49
Zai Lab (ZLAB) China $1.409B 0.00
Gyre Therapeutics (GYRE) United States $1.408B 0.00
ANI Pharmaceuticals (ANIP) United States $1.398B 17.18
ADMA Biologics Inc (ADMA) United States $1.365B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.303B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.277B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.232B 0.00
AbCellera Biologics (ABCL) Canada $1.224B 0.00
Akero Therapeutics (AKRO) United States $1.223B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.210B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.204B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.196B 0.00
Prothena (PRTA) Ireland $1.181B 0.00
Vir Biotechnology (VIR) United States $1.153B 0.00
Immunome (IMNM) United States $1.125B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.124B 0.00
MannKind (MNKD) United States $1.115B 0.00
Belite Bio (BLTE) United States $1.067B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.060B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.044B 0.00
Liquidia Technologies (LQDA) United States $1.040B 0.00
Scholar Rock Holding (SRRK) United States $1.038B 0.00
Kyverna Therapeutics (KYTX) United States $0.987B 0.00
Viridian Therapeutics (VRDN) United States $0.982B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.977B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.942B 0.00
MiMedx (MDXG) United States $0.933B 211.67
Abivax SA (ABVX) France $0.925B 0.00
89BIO (ETNB) United States $0.887B 0.00
REGENXBIO (RGNX) United States $0.884B 0.00
Immatics (IMTX) Germany $0.880B 0.00
Pliant Therapeutics (PLRX) United States $0.816B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.789B 0.00
Cytek Biosciences (CTKB) United States $0.788B 0.00
CARGO Therapeutics (CRGX) United States $0.783B 0.00
Tango Therapeutics (TNGX) United States $0.781B 0.00
Cabaletta Bio (CABA) United States $0.781B 0.00
Tyra Biosciences (TYRA) United States $0.775B 0.00
Nurix Therapeutics (NRIX) United States $0.760B 0.00
Dianthus Therapeutics (DNTH) United States $0.742B 0.00
Disc Medicine (IRON) United States $0.737B 0.00
Pharming Group (PHAR) Netherlands $0.723B 0.00
Cullinan Oncology (CGEM) United States $0.713B 0.00
Praxis Precision Medicines (PRAX) United States $0.707B 0.00
Aerovate Therapeutics (AVTE) United States $0.705B 0.00
WAVE Life Sciences (WVE) Singapore $0.702B 0.00
Pharming Group (PHGUF) Netherlands $0.695B 0.00
HilleVax (HLVX) United States $0.692B 0.00
EnGene Holdings (ENGN) United States $0.688B 0.00
PureTech Health (PRTC) United States $0.688B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.687B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.657B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.656B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.653B 0.00
Prime Medicine (PRME) United States $0.652B 0.00
ALX Oncology Holdings (ALXO) United States $0.646B 0.00
Oric Pharmaceuticals (ORIC) United States $0.643B 0.00
Zymeworks (ZYME) United States $0.641B 0.00
Nuvation Bio (NUVB) United States $0.628B 0.00
Cogent Biosciences (COGT) United States $0.621B 0.00
Mineralys Therapeutics (MLYS) United States $0.612B 0.00
Absci (ABSI) United States $0.612B 0.00
GH Research (GHRS) Ireland $0.610B 0.00
Olema Pharmaceuticals (OLMA) United States $0.607B 0.00
Northwest Biotherapeutics (NWBO) United States $0.604B 0.00
Allogene Therapeutics (ALLO) United States $0.600B 0.00
Astria Therapeutics (ATXS) United States $0.598B 0.00
CureVac (CVAC) Germany $0.593B 0.00
Mesoblast (MESO) Australia $0.590B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.586B 0.00
Novavax (NVAX) United States $0.577B 0.00
ArriVent BioPharma (AVBP) United States $0.569B 0.00
AnaptysBio (ANAB) United States $0.569B 0.00
Stoke Therapeutics (STOK) United States $0.565B 0.00
Fate Therapeutics (FATE) United States $0.560B 0.00
IGM Biosciences (IGMS) United States $0.553B 0.00
Celcuity (CELC) United States $0.551B 0.00
ACELYRIN, INC (SLRN) United States $0.543B 0.00
Alector (ALEC) United States $0.540B 0.00
Applied Therapeutics (APLT) United States $0.536B 0.00
Arbutus Biopharma (ABUS) United States $0.533B 0.00
Castle Biosciences (CSTL) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Annexon (ANNX) United States $0.517B 0.00
Editas Medicine (EDIT) United States $0.497B 0.00
Oculis Holding AG (OCS) Switzerland $0.487B 0.00
Neurogene (NGNE) United States $0.481B 0.00
Travere Therapeutics (TVTX) United States $0.481B 0.00
Third Harmonic Bio (THRD) United States $0.480B 0.00
C4 Therapeutics (CCCC) United States $0.471B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.460B 0.00
Mersana Therapeutics (MRSN) United States $0.460B 0.00
Fulcrum Therapeutics (FULC) United States $0.456B 0.00
Biomea Fusion (BMEA) United States $0.449B 0.00
Voyager Therapeutics (VYGR) United States $0.447B 2.67
Replimune (REPL) United States $0.437B 0.00
Entrada Therapeutics (TRDA) United States $0.433B 0.00
Shattuck Labs (STTK) United States $0.432B 0.00
Nkarta (NKTX) United States $0.431B 0.00
Avid Bioservices (CDMO) United States $0.430B 0.00
Adaptive Biotechnologies (ADPT) United States $0.422B 0.00
ITeos Therapeutics (ITOS) United States $0.422B 0.00
Revance Therapeutics (RVNC) United States $0.414B 0.00
Ocugen (OCGN) United States $0.408B 0.00
MaxCyte (MXCT) United States $0.405B 0.00
Adlai Nortye (ANL) Cayman Islands $0.404B 0.00
Jasper Therapeutics (JSPR) United States $0.396B 0.00
PepGen (PEPG) United States $0.396B 0.00
Alto Neuroscience (ANRO) United States $0.380B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
Amarin (AMRN) Ireland $0.377B 0.00
Anika Therapeutics (ANIK) United States $0.376B 0.00
Aura Biosciences (AURA) United States $0.374B 0.00
TScan Therapeutics (TCRX) United States $0.368B 0.00
Caribou Biosciences (CRBU) United States $0.368B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.361B 0.00
Urogen Pharma (URGN) United States $0.354B 0.00
MeiraGTx Holdings (MGTX) United States $0.351B 0.00
Tenaya Therapeutics (TNYA) United States $0.351B 0.00
Precigen (PGEN) United States $0.348B 0.00
Anavex Life Sciences (AVXL) United States $0.347B 0.00
FibroBiologics (FBLG) United States $0.346B 0.00
Humacyte (HUMA) United States $0.342B 0.00
Invivyd (IVVD) United States $0.335B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.334B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.329B 0.00
Ventyx Biosciences (VTYX) United States $0.329B 0.00
Terns Pharmaceuticals (TERN) United States $0.327B 0.00
Atea Pharmaceuticals (AVIR) United States $0.316B 0.00
Nautilus Biotechnology (NAUT) United States $0.308B 0.00
Erasca (ERAS) United States $0.303B 0.00
Rapt Therapeutics (RAPT) United States $0.297B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
CorMedix Inc (CRMD) United States $0.295B 0.00
Kamada (KMDA) Israel $0.294B 22.26
Inozyme Pharma (INZY) United States $0.291B 0.00
Rani Therapeutics Holdings (RANI) United States $0.289B 0.00
XBiotech (XBIT) United States $0.287B 0.00
XOMA (XOMA) United States $0.283B 0.00
Verastem (VSTM) United States $0.280B 0.00
Contineum Therapeutics (CTNM) United States $0.267B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Puma Biotechnology (PBYI) United States $0.258B 11.63
Inovio Pharmaceuticals (INO) United States $0.257B 0.00
2seventy Bio (TSVT) United States $0.256B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
AC Immune (ACIU) Switzerland $0.249B 0.00
Coherus BioSciences (CHRS) United States $0.248B 0.00
Adverum Biotechnologies (ADVM) United States $0.239B 0.00
Werewolf Therapeutics (HOWL) United States $0.238B 0.00
Cardiff Oncology (CRDF) United States $0.236B 0.00
Poseida Therapeutics (PSTX) United States $0.234B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.234B 81.20
UniQure (QURE) Netherlands $0.227B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
G1 Therapeutics (GTHX) United States $0.225B 0.00
Compass Therapeutics (CMPX) United States $0.217B 0.00
Elevation Oncology (ELEV) United States $0.216B 0.00
Design Therapeutics (DSGN) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
Scilex Holding (SCLX) United States $0.213B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.212B 0.00
X4 Pharmaceuticals (XFOR) United States $0.210B 0.00
Abeona Therapeutics (ABEO) United States $0.209B 0.00
Opthea (OPT) Australia $0.208B 0.00
Kodiak Sciences (KOD) United States $0.203B 0.00
Prima BioMed (IMMP) Australia $0.203B 0.00
Akoya Biosciences (AKYA) United States $0.197B 0.00
Innate Pharma S.A (IPHA) France $0.196B 0.00
23andMe Holding (ME) United States $0.194B 0.00
Trevi Therapeutics (TRVI) United States $0.194B 0.00
Gossamer Bio (GOSS) United States $0.194B 0.00
BioStem Technologies (BSEM) $0.190B 0.00
Lifecore Biomedical (LFCR) United States $0.190B 0.00
Codexis (CDXS) United States $0.189B 0.00
Alimera Sciences (ALIM) United States $0.185B 0.00
Greenwich LifeSciences (GLSI) United States $0.183B 0.00
Adicet Bio (ACET) United States $0.181B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
ScPharmaceuticals (SCPH) United States $0.175B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.173B 0.00
INmune Bio (INMB) United States $0.173B 0.00
Inventiva S.A (IVA) France $0.172B 0.00
Candel Therapeutics (CADL) United States $0.171B 0.00
LENZ Therapeutics (LENZ) United States $0.170B 0.00
Compugen (CGEN) Israel $0.170B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.166B 0.00
Renovaro (RENB) United States $0.163B 0.00
Skye Bioscience (SKYE) United States $0.161B 0.00
Spyre Therapeutics (SYRE) United States $0.151B 0.00
Sagimet Biosciences (SGMT) United States $0.146B 0.00
I-Mab (IMAB) China $0.145B 0.00
Cellectis S.A (CLLS) France $0.145B 0.00
CervoMed (CRVO) United States $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Syros Pharmaceuticals (SYRS) United States $0.143B 0.00
Omega Therapeutics (OMGA) United States $0.139B 0.00
BioAtla (BCAB) United States $0.138B 0.00
Agenus (AGEN) United States $0.136B 0.00
Zura Bio (ZURA) United States $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.134B 0.00
CytomX Therapeutics (CTMX) United States $0.133B 0.00
Repare Therapeutics (RPTX) Canada $0.128B 0.00
VistaGen Therapeutics (VTGN) United States $0.128B 0.00
Vor Biopharma (VOR) $0.123B 0.00
Coya Therapeutics (COYA) United States $0.122B 0.00
Annovis Bio (ANVS) United States $0.122B 0.00
Rezolute (RZLT) United States $0.122B 0.00
Immunic (IMUX) United States $0.118B 0.00
Vigil Neuroscience (VIGL) United States $0.117B 0.00
Seer (SEER) United States $0.116B 0.00
TELA Bio (TELA) United States $0.116B 0.00
ATyr Pharma (LIFE) United States $0.116B 0.00
Adagene (ADAG) China $0.115B 0.00
Nuvectis Pharma (NVCT) United States $0.114B 0.00
Bluebird Bio (BLUE) United States $0.113B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Emergent Biosolutions (EBS) United States $0.104B 0.00
PDS Biotechnology (PDSB) United States $0.103B 0.00
BioHarvest Sciences (CNVCF) Canada $0.103B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.103B 0.00
Cartesian Therapeutics (RNAC) United States $0.102B 0.00
Genelux (GNLX) United States $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
Sangamo Therapeutics (SGMO) United States $0.099B 0.00
Alpha Teknova (TKNO) United States $0.099B 0.00
Clearside Biomedical (CLSD) United States $0.096B 0.00
Allakos (ALLK) United States $0.095B 0.00
Elicio Therapeutics (ELTX) United States $0.094B 0.00
Seres Therapeutics (MCRB) United States $0.093B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.093B 0.00
Connect Biopharma Holdings (CNTB) United States $0.092B 0.00
DiaMedica Therapeutics (DMAC) United States $0.091B 0.00
Precision BioSciences (DTIL) United States $0.090B 0.00
Curis (CRIS) United States $0.086B 0.00
Q32 Bio (QTTB) United States $0.085B 0.00
BioXcel Therapeutics (BTAI) United States $0.084B 0.00
Affimed (AFMD) Germany $0.084B 0.00
YS Biopharma (YS) China $0.083B 0.00
Eton Pharmaceuticals (ETON) United States $0.083B 0.00
Spero Therapeutics (SPRO) United States $0.082B 3.06
InflaRx (IFRX) Germany $0.082B 0.00
Celularity (CELU) United States $0.081B 0.00
Atara Biotherapeutics (ATRA) United States $0.081B 0.00
Oncolytics Biotech (ONCY) Canada $0.080B 0.00
Athira Pharma (ATHA) United States $0.079B 0.00
Cue Biopharma (CUE) United States $0.078B 0.00
Leap Therapeutics (LPTX) United States $0.077B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.076B 0.00
Passage Bio (PASG) United States $0.076B 0.00
MediciNova (MNOV) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
HOOKIPA Pharma (HOOK) United States $0.075B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Cognition Therapeutics (CGTX) United States $0.074B 0.00
AN2 Therapeutics (ANTX) United States $0.074B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.074B 0.00
Entera Bio (ENTX) Israel $0.073B 0.00
Gritstone Bio (GRTS) United States $0.072B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.072B 0.00
Elutia (ELUT) United States $0.071B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.070B 0.00
Immix Biopharma (IMMX) United States $0.070B 0.00
Rallybio (RLYB) United States $0.069B 0.00
BeyondSpring (BYSI) United States $0.069B 0.00
Kronos Bio (KRON) United States $0.069B 0.00
Instil Bio (TIL) United States $0.068B 0.00
Aligos Therapeutics (ALGS) United States $0.068B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
Turnstone Biologics (TSBX) United States $0.065B 0.00
Ocean Biomedical (OCEA) United States $0.065B 0.00
Lantern Pharma (LTRN) United States $0.064B 0.00
Genenta Science S.p.A (GNTA) Italy $0.063B 0.00
Equillium (EQ) United States $0.062B 0.00
Ikena Oncology (IKNA) United States $0.062B 0.00
Checkpoint Therapeutics (CKPT) United States $0.061B 0.00
HCW Biologics (HCWB) United States $0.061B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.059B 0.00
Intensity Therapeutics (INTS) United States $0.057B 0.00
Vaxxinity (VAXX) United States $0.057B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
Immuneering (IMRX) United States $0.056B 0.00
Apollomics (APLM) United States $0.050B 0.00
Dyadic (DYAI) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.048B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.048B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Beyond Air (XAIR) United States $0.047B 0.00
Aadi Bioscience (AADI) United States $0.047B 0.00
NextCure (NXTC) United States $0.047B 0.00
Carmell (CTCX) United States $0.046B 0.00
Ocuphire Pharma (OCUP) United States $0.044B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.043B 0.00
Bolt Biotherapeutics (BOLT) United States $0.043B 0.00
Clene (CLNN) United States $0.043B 0.00
SAB Biotherapeutics (SABS) United States $0.043B 0.00
Promis Neurosciences (PMN) Canada $0.041B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Cara Therapeutics (CARA) United States $0.039B 0.00
Estrella Immunopharma (ESLA) United States $0.039B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.038B 0.00
Semper Paratus Acquisition (TVGN) United States $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.037B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.033B 0.00
IN8bio (INAB) United States $0.033B 0.00
Aprea Therapeutics (APRE) United States $0.032B 0.00
Prenetics Global (PRE) Cayman Islands $0.032B 0.00
BioAffinity Technologies (BIAF) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.032B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Femasys (FEMY) United States $0.030B 0.00
Pluri (PLUR) Israel $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Aileron Therapeutics (ALRN) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
NKGen Biotech (NKGN) United States $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.026B 0.00
Lexaria Bioscience (LEXX) Canada $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.022B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
Lumos Pharma (LUMO) United States $0.020B 0.00
KALA BIO (KALA) United States $0.020B 0.00
RenovoRx (RNXT) United States $0.019B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
Vincerx Pharma (VINC) United States $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.017B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Aytu BioPharma (AYTU) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Purple Biotech (PPBT) Israel $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.014B 0.00
Imunon (IMNN) United States $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Organovo Holdings (ONVO) United States $0.014B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Telesis Bio (TBIO) United States $0.011B 0.00
Adial Pharmaceuticals (ADIL) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.009B 0.00
NuCana (NCNA) United Kingdom $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
TFF Pharmaceuticals (TFFP) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Chemomab Therapeutics (CMMB) Israel $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
Longeveron (LGVN) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
First Wave BioPharma (FWBI) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Seelos Therapeutics (SEEL) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.36
GT Biopharma (GTBP) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Kineta (KA) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00